首页> The Journal of molecular diagnostics : JMD> miR-210 is a prognostic marker in clear cell renal cell carcinoma.

miR-210 is a prognostic marker in clear cell renal cell carcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sara,Samaan

第一单位： Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada.

作者： Sara,Samaan ^[1] ; Heba W Z,Khella ^[1] ; Andrew,Girgis ^[1] ; Andreas,Scorilas ^[2] ; Evi,Lianidou ^[3] ; Manal,Gabril ^[4] ; Sergey N,Krylov ^[5] ; Michael,Jewett ^[6] ; Georg A,Bjarnason ^[7] ; Hala,El-said ^[8] ; George M,Yousef ^[9]

作者单位： Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada. ^[1] Departments of Biochemistry and Molecular Biology, University of Athens, Athens, Greece. ^[2] Department of Chemistry, University of Athens, Athens, Greece. ^[3] Department of Pathology, London Health Sciences Center and Western University, London, Ontario, Canada. ^[4] Department of Chemistry, York University, Toronto, Ontario, Canada; Centre for Research on Biomolecular Interactions, York University, Toronto, Ontario, Canada. ^[5] Division of Urologic Oncology, Princess Margaret Hospital, University Health Network, Toronto, Ontario, Canada; Department of Surgery, University of Toronto, Toronto, Ontario, Canada. ^[6] Division of Medical Oncology and Hematology, Sunnybrook Odette Cancer Center, Toronto, Ontario, Canada. ^[7] Biochemistry Department, The National Liver Institute, Menoufiya University, Al-Minufya, Egypt. ^[8] Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Electronic address: yousefg@smh.ca. ^[9]